PubMed Health⌕ Search

Biomedical subjects

L L Gonçalves

Publications and source records attributed to L L Gonçalves.

2 recordsLinked to original sources

Relaxation in kinetic models on alternating linear chains.

A restricted dynamics, previously introduced in a kinetic model for relaxation phenomena in linear polymer chains, is used to study the dynamic critical exponent of one-dimensional Ising models. Both an alternating isotopic chain and an alternating-bond chain are considered. In contrast with what occurs for Glauber dynamics, in these two models the dynamic critical exponent turns out to be the same. The alternating isotopic chain with the restricted dynamics is shown to lead to Nagel scaling for temperatures above some critical value. Further support is given relating the Nagel scaling to the existence of multiple (simultaneous) relaxation processes, the dynamics apparently not playing the most important role in determining such scaling.

Journal Article↗

Synthesis, characterization, and comparative 32P-postlabeling efficiencies of 2,6-dimethylaniline-DNA adducts.

2,6-Dimethylaniline (2,6-diMeA) is a ubiquitous environmental pollutant that is used in industry as a synthetic intermediate. It is also found in tobacco smoke and as a major metabolite of lidocaine. Although the potential carcinogenicity of 2,6-diMeA in humans is presently uncertain, this aromatic amine has been classified as a rodent carcinogen. In addition, it is known to form hemoglobin adducts in humans, which indicates a profile of metabolic activation similar to that of typical arylamine carcinogens. Like other aromatic amines, 2,6-diMeA has been shown to yield N-(deoxyguanosin-8-yl)-2,6-dimethylaniline (dG-C8-2,6-diMeA) as a major DNA adduct in vitro. In this study, we show that 2,6-diMeA yields an unusual pattern of DNA adducts. In addition to dG-C8-2,6-diMeA, we have isolated two new adducts, 4-(deoxyguanosin-N(2)-yl)-2,6-dimethylaniline (dG-N(2)-2,6-diMeA) and 4-(deoxyguanosin-O(6)-yl)-2,6-dimethylaniline (dG-O(6)-2,6-diMeA), from the reaction of N-acetoxy-2,6-dimethylaniline with deoxyguanosine. A similar reaction conducted with deoxyadenosine yielded 4-(deoxyadenosin-N(6)-yl)-2,6-dimethylaniline (dA-N(6)-2,6-diMeA). All four adducts were detected in DNA reacted with N-acetoxy-2,6-dimethylaniline, with the relative yields being 46% for dA-N(6)-2,6-diMeA, 22% for dG-N(2)-2,6-diMeA, 20% for dG-O(6)-2,6-diMeA, and 12% for dG-C8-2,6-diMeA. This product profile contrasts markedly with the usual pattern of adducts obtained with aromatic amines, where C8-substituted deoxyguanosine products typically predominate. We further analyzed the kinetics of the T(4) polynucleotide kinase (PNK)-catalyzed phosphorylation of the C8 and N(2) deoxyguanosine 3'-phosphate adducts from 2,6-diMeA. The kinetic parameters obtained with these two structurally different adducts are compared to those determined with the parent nucleotide (dG3'p), and with (+/-)-anti-10-(deoxyguanosin-N(2)-yl)-7,8,9-trihydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene 3'-phosphate, the major adduct derived from the environmental pollutant benzo[a]pyrene. The results indicate that all the adducts were labeled with lower efficiencies than dG3'p, stressing the likely underestimation of adduct levels in typical 32P-postlabeling protocols. Nonetheless, the N(2) adducts derived from 2,6-diMeA and benzo[a]pyrene were both labeled with higher efficiencies than the C8 adduct derived from 2,6-diMeA, with the benzo[a]pyrene adduct being the best substrate for PNK. Thus, the data suggest that N(2) adducts from dG3'p are intrinsically better substrates than their C8 analogues for PNK, and that bulkier aromatic fragments may favor the enzyme-substrate interaction during the labeling step.

Aniline Compounds↗